Virgin Galactic's shares have cratered to near $3, presenting a stark dilemma for investors. While a traditional valuation model suggests a staggering 95% discount, the market's skepticism reflects deep-seated concerns over the company's path to profitability in the nascent space tourism sector.
Shares of Bitmine Immersion Technologies (BMNR) have tumbled nearly 10% this week, extending a volatile trend. Trading at a significant discount to peers on a price-to-book basis, the crypto-linked firm presents a conundrum: is its low valuation a buying opportunity, or a red flag for its loss-making business model?
After years of relentless growth, a cooling trend is taking hold in several Western U.S. housing markets. We examine the metros where prices are falling, what's driving the change, and how prospective buyers can navigate this shifting landscape.
Exelixis shares have delivered impressive multi-year returns, but recent price weakness has investors questioning if the rally has run its course. A deep dive into valuation models suggests the stock may still be significantly undervalued, presenting a potential opportunity amidst market uncertainty.
The iconic pottery maker reports encouraging sales growth and a renewed focus on its craft heritage, aiming to return to profitability next year after a period of job cuts and industry-wide challenges.
The Singapore-listed food company has turned profitable after years of losses, with a 12% return on capital employed and a significant expansion in its capital base—key indicators watched by investors seeking compounding growth stocks.
Snapchat has disabled hundreds of thousands of accounts belonging to users under 16 in Australia under new social media laws, but warns the legislation contains 'significant gaps' that may allow some minors to bypass protections.
Travere Therapeutics faces a securities fraud investigation by Robbins Geller Rudman & Dowd LLP, raising questions about the accuracy of its past disclosures. The probe casts a shadow over the company's critical transition, as it banks on its kidney drug FILSPARI to drive growth amid mounting legal and commercial pressures.
Shares of Advantest Corp. have surged nearly 200% in the past year, riding the AI and advanced chipmaking wave. As the stock trades near record highs, investors are grappling with a critical question: has the rally run too far, too fast?
Sanofi's experimental oral drug venglustat demonstrated significant neurological benefits for patients with Type 3 Gaucher disease in a late-stage trial, but failed to meet its primary endpoint in a separate study for Fabry disease, casting uncertainty on its regulatory path.
Two of the largest known Ethereum holders, BitcoinOG and Trend Research, have strategically sold a combined $371 million worth of ETH to repay loans on the Aave protocol. This voluntary deleveraging, distinct from over $140 million in automated liquidations processed by Aave, highlights a shift towards caution among major crypto players amid market volatility.
While 'story stocks' captivate with promise, Begbies Traynor Group (LON:BEG) is drawing a different kind of investor attention. The UK-based business recovery and insolvency specialist is showcasing strong earnings growth, expanding margins, and significant insider investment, positioning it as a notable contender in the current market landscape.
Sportradar Group's shares have tumbled over 22% year-to-date, sparking debate among investors. While a discounted cash flow model suggests significant undervaluation, its lofty P/E ratio tells a conflicting story. We examine the data and gather expert opinions on the sports tech giant's true worth.
A deep-dive valuation using a Discounted Cash Flow model suggests Avolta AG's shares are trading close to their intrinsic fair value. We break down the assumptions, the numbers, and the critical factors investors should consider beyond the model.
Vital Farms shares have tumbled over 35% in the past year, lagging the broader market. A deep dive into valuation metrics, including DCF analysis and P/E comparisons, suggests the stock may be significantly undervalued. But is the market missing something?
A senior Iranian official has refuted earlier media claims that the Islamic Revolutionary Guard Corps (IRGC) Navy would conduct live-fire military exercises in the vital Strait of Hormuz this week, calling the reports inaccurate.
Tens of thousands gathered in Prague's Wenceslas Square on Sunday, voicing support for President Petr Pavel in his escalating constitutional dispute with Prime Minister Andrej Babiš's coalition government. The protest, organized by pro-democracy activists, highlights deep divisions over Ukraine policy and a controversial ministerial appointment.
From Mussolini's Rome-Berlin Axis to Bush's 'Axis of Evil,' the term has evolved from a descriptive label to a powerful political tool, framing global rivalries and shaping diplomatic realities.
ArcBest (ARCB) presents a complex valuation picture, with a discounted cash flow model suggesting deep undervaluation while its P/E ratio signals potential overpricing. As the stock hovers around $90, investors weigh conflicting signals against a backdrop of shifting freight demand and industry consolidation.
As the U.S. wine industry grapples with a multi-year slump, iconic tasting rooms are shuttering. The latest casualty is Hall of Fame NFL coach Dick Vermeil's Napa venue, a move reflecting broader shifts in consumer habits and market pressures.
